Bayer's KERENDIA® (finerenone) Receives New Recommendations From American Diabetes Association for Improving Cardiovascular Outcomes and Managing Patients With Chronic Kidney Disease Associated With Type 2 Diabetes

Press/Media

Period28 Jun 2022

Media coverage

5

Media coverage